Literature DB >> 12487945

[Implementation and evaluation of case management in Catalonia: the ISP-SMD program].

J Balsera Gómez1, C Rodríguez Medina, R Caba Calvet, R Vega Prada, H Ruiz Ureña, L Berruezo Ortiz, D Clusa Gironella, M J Rodríguez Montes, J M Haro Abad.   

Abstract

INTRODUCTION: The pilot study of the Individualized Service Program for people with Severe Mental Disorders (ISP-SMD) consists of the implementation of case management services in Catalonia.
METHODOLOGY: The ISP-SMD has been implemented in two health care sectors and will be expanded to the rest of Catalonia in the next years. The program serves people with persistent mental disorders who have serious social or family problems and/or who have inadequate mental health service use (high use of inpatient services, no use of community services). The ISP-SMD is a community intervention program that focuses its activities on direct care and coordination between services. Thirty patients have been included in the evaluation.
RESULTS: The results of the pilot study have shown that, compared to the year before entering the program, the patients show better clinical status, they decrease their unmet need level, they have more appropriate use of health services and have lower treatment costs. Satisfaction of the patients, family members and professionals with the program is very high.
CONCLUSION: It is possible to adapt and implement case management services in Catalonia. When implemented, they improve patient quality of life.

Entities:  

Mesh:

Year:  2002        PMID: 12487945

Source DB:  PubMed          Journal:  Actas Esp Psiquiatr        ISSN: 1139-9287            Impact factor:   1.196


  1 in total

1.  A Method to Compare the Delivery of Psychiatric Care for People with Treatment-Resistant Schizophrenia.

Authors:  Anna Alonso-Solís; Susana Ochoa; Eva Grasa; Katya Rubinstein; Asaf Caspi; Kinga Farkas; Zsolt Unoka; Judith Usall; Elena Huerta-Ramos; Matti Isohanni; Jussi Seppälä; Elisenda Reixach; Jesús Berdún; Iluminada Corripio; M-Resist Group
Journal:  Int J Environ Res Public Health       Date:  2020-10-16       Impact factor: 3.390

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.